Glucotrack’s Collapse: 70% Decline, Reverse Split, and Dire Future for Investors
Glucotrack’s stock collapses to 60 ¢, with a 70% loss MTD and a reverse split—high‑interest debt, weak product and plummeting confidence threaten its future. Explore the full breakdown.
4 minutes to read